Powered by: www.cafestocks.com
Dr. Reddys Laboratories has entered into agreements with Schering and Sepracor which will allow Dr. Reddy's to manufacture and market generic versions of the CLARINEX-D -12 Hour and CLARINEX D - 24 Hour products, with six months marketing exclusivity, and the CLARINEX REDITABS product, with six months marketing co-exclusivity, starting in 2012. Dr. Reddy's will also market a generic version of the CLARINEX 5 milligram tablet six months after the launch of the first generic version of that product.
Indian Stock Market
No comments:
Post a Comment